Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Epidemiology and Community Health 2007;61:1018-1019; doi:10.1136/jech.2007.059832
Copyright © 2007 by the BMJ Publishing Group Ltd.

EDITORIAL

HPV vaccine

HPV vaccine: positive insights from universal adolescent HepB vaccination

J Claire Cameron1, Lesley A Wallace1, Syed Ahmed2, Rina Duff3, Martin Donaghy1, David J Goldberg1

1 Health Protection Scotland, Glasgow, UK
2 NHS Greater Glasgow and Clyde, Glasgow, UK
3 East Renfrewshire Community Health Care Partnership, Glasgow, UK

Correspondence to:
Dr J Claire Cameron, Epidemiologist (Immunisation), Health Protection Scotland, Clifton House, Clifton Place, Glasgow G3 7LN, UK; claire.cameron@hps.scot.nhs.uk


The introduction of universal adolescent HPV vaccination in schools has a positive outlook

Abbreviations: HPV, human papillomavirus

The first 150 words of the full text of this article appear below.

Preventing cervical cancer by vaccination has become a reality, complementing highly successful screening programmes. One vaccine against human papillomavirus (HPV) is already licensed (Gardasil®, Sanofi Pasteur), and approval for a second (Cervarix®, GSK) is expected shortly. Trials indicate over 90% efficacy in preventing persistent infection with vaccine types (HPV-16 and 18).1 2 In several countries, including the United States, Canada, Australia, Austria, Italy, Germany and France, HPV vaccination has now been universally recommended. Other countries, including the UK, are considering recommendations for its use.

The clinical benefit of HPV vaccines is incontrovertible, and excellent safety profiles have been established. As HPV is a sexually transmitted infection, however, some groups are anxious that vaccination may encourage earlier sexual activity.3 Further, uncertainty about the programme’s optimal delivery setting remains.3

However, precedents exist. First, with rubella, against which many countries vaccinated adolescent schoolgirls to protect during later pregnancy, and more recently with . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

In this issue
Carlos Alvarez-Dardet, John Ashton
J Epidemiol Community Health 2007 61: 1017. [Extract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest infectious diseases and epidemilogy jobs

Infectious diseases and epidemilogy jobs